Shoulder Innovations, Inc.: stock overview

SINYSEHealthcare · Surgical & Medical Instruments & Apparatus

Price

$20.69

November 13, 2026Market cap $427M

What Ploutos Investor adds for Shoulder Innovations

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Shoulder Innovations had revenue of $64M over the last 12 months and a net loss of $33M. It holds more cash than debt, by $77M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$427M
20.65M shares
P/E
–
Revenue, 12 months
$64M
+49.6% a year over 1 years
Net margin
-51.7%
2025: -85.3%, above 4% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

2 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2024–2025 fiscal years
  • 202510-K
    Revenue$47M
  • 2024
    Revenue$32M

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 
$427M
Enterprise value 
$350M
P/E 
–
EV / EBIT 
–
EV / Revenue 
5.4
P/B 
3.6
FCF yield 
–
Earnings yield 
–

Profitability

Gross margin 
77.8%
Operating margin 
-54.4%
Net margin 
-51.7%
ROIC 
-18.8%
ROIC, 5-year average 
-13.4%
ROE 
-25.1%

Growth

Revenue, yearly change 
+49.6%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
+49.6%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$92M
Total debt 
$15M
Of which operating leases 
$37.0K
Net cash 
$77M
Net debt / EBITDA 
–
Interest cover 
–
Current ratio 
10.68

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+24,515.0%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

76.5%

Above 87% of the 161 companies in its industry, and 92% of all.

Operating margin

-55.6%

Above 12% of the 186 companies in its industry, and 7% of all.

Net margin

-85.3%

Above 4% of the 189 companies in its industry, and 4% of all.

ROE

-28.7%

Above 22% of the 174 companies in its industry, and 11% of all.

ROA

-23.8%

Above 16% of the 190 companies in its industry, and 8% of all.

Revenue growth

49.6%

Above 97% of the 186 companies in its industry, and 94% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
SHOULDER INNOVATIONS, INC.
Exchange
NYSE
Industry (SIC)
3841 · Surgical & Medical Instruments & Apparatus
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
20.65M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Shoulder Innovations's filings show?

These are Shoulder Innovations's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SI

Didn't find what you were looking for?

Ask us
What is SI's market cap?

Shoulder Innovations, Inc.'s market cap is $427M, at a price of $20.69 on November 13, 2026 and 20.65M shares.

How much revenue does SI have?

Shoulder Innovations had revenue of $64M over the last 12 months. Over the last 1 years it changed by +49.6% a year on average.

Does SI pay a dividend?

No. Shoulder Innovations paid no regular dividend over the last 12 months.

Where do the figures come from?

From Shoulder Innovations, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.